TODD WILLIAM BUTLER,TRAVIS T. WAGER,RAMALAKSHMI YEGNA CHANDRASEKARAN
申请号：
PT06809114
公开号：
PT1951660E
申请日:
2006.10.16
申请国别(地区):
PT
年份:
2014
代理人:
摘要：
This invention is directed to a compound of formula I, as defined herein, or a pharmaceutically acceptable salt thereof； a pharmaceutical composition containing a compound of formula I, a process of preparation of a compound of formula I, a method of treatment of a disorder or condition that may be treated by antagonizing histamine H3 receptors, the method comprising administering to a mammal in need of such treatment a compound of formula I as described above, and a method of treatment of a disorder or condition selected from the group consisting of depression, mood disorders, schizophrenia, anxiety disorders, Alzheimer's disease, attention-deficit hyperactivity disorder (ADHD), psychotic disorders, cognitive disorders, sleep disorders, obesity, dizziness, epilepsy, motion sickness, respiratory diseases, allergy, allergy-induced airway responses, allergic rhinitis, nasal congestion, allergic congestion, congestion, hypotension, cardiovascular disease, diseases of the GI tract, hyper and hypo motility and acidic secretion of the gastro-intestinal tract, the method comprising administering to a mammal in need of such treatment a compound of formula I as described above.
